Try our Advanced Search for more refined results
New Jersey - August, 2010
66 articles
- 3rd Circ. Lets Sabinsa's Win In Trademark Suit Stand
- Salix Settles With Novel Over Generic MoviPrep
- AT&T Counterclaim Survives In $427M Coverage Suit
- Alleged Ponzi Artist Who Can't Pay Atty Not Off Hook: US
- 3rd Circ. To Review Tossed $295M De Beers Settlement
- Real Estate Schemer Weinstein Out On $10M Bail
- Cooley Reps Bravo Health In $545M HealthSpring Buy
- Lilly Gets Longer Reprieve On Strattera Appeal
- New Trial Ordered On $32M In Damages Against KPMG
- Calif. Lawmakers Limit Cadmium In Kids' Jewelry
- Paul Weiss, Lowenstein Fined $2M For 'Frivolous' Suit
- Phoenix Dividend Suit To Proceed On Most Claims
- Boniva ANDAs Infringe Roche Patent: Judge
- Blood Reagent Price-Fixing MDL Survives Dismissal Bid
- FDA Warns J&J Unit Over Joint Product Marketing
- Chemtura To Pay $26M To Settle Cleanup Claims
- Insurer Suit To Duck Crash Coverage Dismissed
- PPL Strikes Deal With Park Service Over Pruning
- NJ High Court's Guidance Expanding Spoliation Analysis
- Schering Goes After Impax Over Vytorin ANDA
- Liberty Calls PATH's Dropping Of $7M Suit A 'Ploy'
- St. Vincent's Gets Green Light On 4 Asset Sales
- DLA Piper Adds 6 Hogan Lovells IP Litigators In LA
- NJ Court Affirms $9M Asbestos Award Against Exxon
- Wockhardt Exits Sepracor's Lunesta Patent Suit
- Mylan Violated Mirapex Patent, Judge Rules
- Class Certified In Century 21 Franchisee Contract Feud
- Lilly Wins Short Ban On Generic Strattera
- Dell Fails To Compel Arbitration In Defective Laptop Suit
- Sills Cummis Eludes Ex-NJ Bank Execs' Malpractice Suit
- NJ Settles With SEC Over $26B Bond Offerings
- Most Admired Attys: Skadden's Scott Musoff
- Schering Shareholders Win Access To Board Notes
- Pepper Hamilton Loses Rangers CEO To Reed Smith
- Lilly Seeks To Block Generic Strattera Amid Appeal
- WellPoint, Aetna Antitrust Suits Barred By Past Deals
- Most Admired Attys: Cravath's Richard Clary
- Linens 'N Things Noteholder Loss Suit Booted
- Pfizer Targets Actavis Over Generic Lipitor
- NJ Man Charged In $200M Jewish Real Estate Scheme
- Lilly's Patent For ADHD Drug Strattera Found Invalid
- Iowa Fund Seeks To Join Lehman Securities Case
- Snapple Label Action Stayed Pending FDA Feedback
- Icahn Sues Tropicana Las Vegas Over Trademark
- FDA Warns CorePharma Over Manufacturing Issues
- Sanofi Fails To Shake Eisai's Lovenox Antitrust Suit
- PPL Sues Park Service Over Pruning Barriers
- Coke Wins Dismissal Of 'Calorie-Burning' Enviga Suit
- 3rd Circ. Revives Blueberry Farmers' Suit V. Novartis
- Investors Back Out Of Synchronoss Securities Case
- LeClairRyan Taps Successor For CEO Spot
- AstraZeneca To Pay $198M To End Seroquel Suits
- NJ County, Gas Co. To Pay $1.3M Over Landfill Gases
- Spansion Hits Samsung, Others With 337 Complaint
- Glenmark Settles Lunesta Patent Spat With Sepracor
- 3rd Circ. Clears Fox Rothschild In Corruption Suit
- CVS Assistant Managers Win Class Status In OT Case
- St. Vincent's Moves To Sell Off 2 Nursing Homes
- $10M Verdict For Accutane User Nixed On Appeal
- Samsung Settlement Over Defective HDTVs OK'd
- Levi's, Revise Spar Over Jeans Pocket Designs
- AstraZeneca Puts 4K Seroquel Injury Claims To Bed
- NJ High Court Sets Guidance For Spoliation Sanctions
- Wal-Mart, J&J Get Baby Shampoo Class Suits Tossed
- Paperboard Maker Newark Sails To Ch. 11 Finish Line
- Pfizer Win In Vaccine-Related Cancer Suit Overturned